Entry Detail



General Information

Database ID:exR0755080
RNA Name:NORAD
RNA Type:lncRNA
Chromosome:chr20
Starnd:-
Coordinate:
Start Site(bp):36045618End Site(bp):36051018
External Links:ENSG00000260032



Disease Information

Disease Name:Glioblastoma Multiforme
Disease Category:Cancers
MeSH ID:D005909
Type:Neoplasms/Neoplasms, Glandular and Epithelial
Alias:Glioblastoma//Glioblastomas//Astrocytoma, Grade IV//Astrocytomas, Grade IV//Grade IV Astrocytoma//Grade IV Astrocytomas//Glioblastoma Multiforme//Giant Cell Glioblastoma//Giant Cell Glioblastomas//Glioblastoma, Giant Cell//Glioblastomas, Giant Cell



Expression Detail

GEO ID:GSE106804
Description:Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles
Experimental Design:Cancer vs Control
Case Disease Type:Glioblastoma Multiforme
Case Disease SubType:NA
Case Sample:Glioblastoma Multiforme
Control Sample:Healthy
Number of Case:13
Number of Control:6
Number of Samples:19





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
AASS
chr7
122073549
122144255
-
ADIPOR1
chr1
202940826
202958572
-
AGRN
chr1
1020120
1056118
+
AKR1B1
chr7
134442356
134459284
-
miRNA targets:
miRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa-miR-132-5p
chr17
2049965
2049986
-
hsa-miR-576-5p
chr4
109488713
109488734
+
hsa-miR-496
chr14
101060628
101060649
+
hsa-miR-888-5p
chrX
145994830
145994850
-
hsa-miR-520d-3p
chr19
53720149
53720170
+
hsa-miR-199b-3p
chr9
128244745
128244766
-
hsa-miR-302c-3p
chr4
112648366
112648388
-
hsa-miR-1306-5p
chr22
20086072
20086093
+
hsa-miR-1297
chr13
54311981
54311997
-
hsa-miR-106a-5p
chrX
134170244
134170266
-
hsa-miR-371a-5p
chr19
53787680
53787699
+
hsa-miR-4424
chr1
178677763
178677784
+
hsa-miR-3187-3p
chr19
813627
813646
+
hsa-miR-4262
chr2
11836943
11836959
-
hsa-miR-106b-5p
chr7
100094043
100094063
-
hsa-miR-384
chrX
76919285
76919304
-
hsa-miR-302d-3p
chr4
112648006
112648028
-
hsa-miR-1245b-5p
chr2
188978133
188978153
-
hsa-miR-181b-5p
chr9
124693725
124693747
+
hsa-miR-324-3p
chr17
7223308
7223330
-
hsa-miR-520c-3p
chr19
53707506
53707527
+
hsa-miR-520d-5p
chr19
53720111
53720130
+
hsa-miR-373-3p
chr19
53788748
53788770
+
hsa-miR-378e
chr5
170028545
170028563
+
hsa-miR-17-5p
chr13
91350618
91350640
+
hsa-miR-511-3p
chr10
17845160
17845179
+
hsa-miR-518d-5p
chr19
53734892
53734913
+
hsa-miR-580-3p
chr5
36147907
36147928
-
hsa-miR-485-3p
chr14
101055464
101055485
+
hsa-miR-20b-5p
chrX
134169850
134169872
-
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC005082.1
chr7
23205787
23208045
+
AC099499.2
chr5
25188059
25188778
-
AD000090.1
chr19
35557956
35581954
+
Display:



Experiment Detail

GEO ID:NA
Sample Source:NA
Source Fraction:NA
Platform:NA
Method:NA
Num of detected RNA Type:NA
Num of detected RNAs of this Type:NA
Sample treatment protocol:NA
RNA Extract protocol:NA
RNA library preparation protocol:NA



Reference

PMID:29330365
Title:Engineered nanointerfaces for microfluidic isolation and molecular profiling of tumor-specific extracellular vesicles.
Author:Re¨¢tegui E, van der Vos KE, Lai CP, Zeinali M, Atai NA, Aldikacti B, Floyd FP Jr, H Khankhel A, Thapar V, Hochberg FH, Sequist LV, Nahed BV, S Carter B, Toner M, Balaj L, T Ting D, Breakefield XO, Stott SL.
Journal:Nat Commun. 2018 Jan 12;9(1):175.
Description:Tumor-derived EVs have the potential to be utilized as disease-specific biomarkers, and genes specific to GBM as well as transcripts that are hallmarks for the four genetic subtypes of the disease.